April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Detection and Registration of Risk Factors for Malignant Transformation at the First Consultation of Choroidal Nevi
Author Affiliations & Notes
  • Maria P. Mera
    Ophthalmology, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Manuel F. Bande
    Ophthalmology, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Maria Santiago
    Ophthalmology, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Maria Pardo
    Grupo de Obesidómica. Laboratorio de endocrinologia Molecular y Celular, Hospital Clinico Universitario de Santiago (CHUS/SERGAS), Santiago de Compostela, Spain
  • Carmen Capeans
    Ophthalmology, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Antonio Pineiro
    Ophthalmology, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Maria J. Blanco
    Ophthalmology, University of Santiago de Compostela, Santiago de Compostela, Spain
  • Footnotes
    Commercial Relationships  Maria P. Mera, None; Manuel F. Bande, None; Maria Santiago, None; Maria Pardo, None; Carmen Capeans, None; Antonio Pineiro, None; Maria J. Blanco, None
  • Footnotes
    Support  Conselleria de Sanidade-Xunta de Galicia grant PS09/7
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3264. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria P. Mera, Manuel F. Bande, Maria Santiago, Maria Pardo, Carmen Capeans, Antonio Pineiro, Maria J. Blanco; Detection and Registration of Risk Factors for Malignant Transformation at the First Consultation of Choroidal Nevi. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3264.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

Seven clinical and ultrasonographic factors have been described to identify those choroidal nevi (CN) with risk of transformation into malignant melanomas: thickness > 2 mm, orange pigment, symptoms, subretinal fluid, margin minor than 3 mm from optic disc, absence of atrophic halo and acoustic hollowness. The aim of this study is to describe our experience assessing and registering the presence of risk factors (RF) for malignant transformation at the first consultation.

 
Methods:
 

104 CN from 103 patients have been consecutively studied at our Unit. A complete ophthalmic and ultrasonographic examination was carried out in all cases. Moreover, an OCT examination was made in all cases to identify the presence of subretinal fluid related to the mass. Retinographs were taken in all cases. Visual symptoms were those directly related with the presence of the choroidal nevi (visual acuity diminution, floaters, photopsia, metamorphopsia). Orange pigment was studied by means of biomicroscopy and retinography. Quantitative standardized ultrasonography was used to find the presence of acoustic hollowness.

 
Results:
 

74 women and 29 men with a mean age of 61.77 years (SD= 14.668; range: 21-90) were included in this study. 104 eyes were studied (50 right and 54 left). The more frequent RF was absence of atrophic halo, and the less frequent RF was thickness > 2mm. A 34.1% of patients had 1 RF, 27.3% have 2 RF, 15.9% 3 RF, 6.8% 4 RF, 11.4% 5 RF, 2.3% 6 RF and 2.3% 7 RF. However, a 57.7% of patients had more than 2 RF not registered or missed at the first examination.

 
Conclusions:
 

Nowadays the detection of CN with risk of transformation in malignant melanoma should be exhaustive. The authors think each RF must be adequately searched and registered. In patients with CN, evaluation and progression of their RF could be essential to plan the follow-up and suitable treatment.

 
Keywords: melanoma • choroid • clinical (human) or epidemiologic studies: risk factor assessment 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×